
Bupropion Hydrochloride
150 mg/1 · Extended-Release Tablet
By Exelan Pharmaceuticals Inc.
- NDC
- 76282-480
- Route
- Oral
- Therapeutic class
- Aminoketone , Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- ANDA
Package sizes
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-30)NDC 76282-480-30Available to order
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-90)NDC 76282-480-90Available to order
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-480-05)NDC 76282-480-05Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

